(Q53677825)

17 May 2018

title

Increased angiogenesis and Fas-ligand expression are independent processes in acute myeloid leukemia. (English)

1 reference

17 May 2018

1 reference

Lee JJ

1 reference

17 May 2018

Chung IJ

1 reference

17 May 2018

Park MR

1 reference

17 May 2018

Ryang DW

1 reference

17 May 2018

Park CS

1 reference

17 May 2018

Kim HJ

1 reference

17 May 2018

publication date

1 December 2001

1 reference

17 May 2018

published in

Leukemia Research

1 reference

17 May 2018

volume

1 reference

17 May 2018

issue

1 reference

17 May 2018

page(s)

1067-1073

1 reference

17 May 2018

Angiogenesis in cancer, vascular, rheumatoid and other disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900082-0

7 January 2021

Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900082-0

7 January 2021

Tumour angiogenesis and prognosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900082-0

7 January 2021

Angiogenesis in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900082-0

7 January 2021

Human Fas ligand: gene structure, chromosomal location and species specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900082-0

7 January 2021

THP-1 monocytic leukemia cells express Fas ligand constitutively and kill Fas-positive Jurkat cells

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900082-0

7 January 2021

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900082-0

7 January 2021

Fas ligand is highly expressed in acute leukemia and during the transformation of chronic myeloid leukemia to blast crisis.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900082-0

7 January 2021

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900082-0

7 January 2021

Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900082-0

7 January 2021

Microvessel density, p53 overexpression, and apoptosis in invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900082-0

7 January 2021

Antitumor activity of thalidomide in refractory multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900082-0

7 January 2021

Therapy with thalidomide in refractory multiple myeloma patients - the revival of an old drug

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900082-0

7 January 2021

Inhibition of angiogenesis by anthracyclines and titanocene dichloride

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900082-0

7 January 2021

Antiangiogenic potential of camptothecin and topotecan

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900082-0

7 January 2021

Vascular endothelial growth factor, a potent and selective angiogenic agent

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900082-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900082-0

1 reference

7 January 2021

Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900082-0

7 January 2021

Donor lymphocyte infusions

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900082-0

7 January 2021

10.1016/S0145-2126(01)00082-0

Identifiers

DOI

1 reference

17 May 2018

1 reference

17 May 2018